弘森药业 (873735.oc)

+ 收藏

利润表(弘森药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2022年年报2022年三季报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 403,208,708.49290,450,086.53225,827,272.71361,004,989.31268,702,837.84182,159,316.91
 营业收入(元) 403,208,708.49290,450,086.53225,827,272.71361,004,989.31268,702,837.84182,159,316.91
二、营业总成本(元) 298,321,526.88210,204,752.87150,659,135.52261,563,552.92194,147,352.27130,528,397.18
 营业成本(元) 172,521,610.27120,893,047.7986,881,343.69130,137,991.2492,380,947.3362,587,817.54
 研发费用(元) 31,494,991.0818,267,148.7110,154,823.2117,833,193.249,153,200.456,036,017.50
 营业税金及附加(元) 3,823,851.842,888,507.502,283,975.073,558,951.292,753,062.081,805,550.99
 销售费用(元) 52,250,195.4841,978,233.8832,383,490.7682,040,968.6066,239,740.6145,366,195.61
 管理费用(元) 38,266,500.6126,356,342.0019,273,892.0927,643,311.4623,414,740.3914,555,473.56
 财务费用(元) -35,622.40-178,527.01-318,389.30349,137.09205,661.41177,341.98
  其中:利息费用(元) 391,006.96323,430.57188,600.01725,792.49564,371.66424,371.66
  其中:利息收入(元) 410,425.60263,640.57219,799.10374,119.71202,654.88113,272.15
三、其他经营收益
 加:投资收益(元) 389,386.31356,438.36356,438.36152,177.92152,177.92148,063.24
 资产处置收益(元) 39,627.6142,970.1742,970.173,574,489.29--
 资产减值损失(元) -1,983,345.33-2,160,171.63-1,800,279.43-2,507,562.13--1,039,131.07
 信用减值损失(元) -46,957.89-20,088.78-37,949.34-44,928.01--35,590.91
 其他收益(元) 3,563,720.471,991,766.921,844,010.924,448,359.582,179,366.4146,427.41
四、营业利润(元) 106,849,612.7880,456,248.7075,573,327.87105,063,973.0476,887,029.9050,750,688.40
 加:营业外收入(元) 2,349.721,738.731.00141,869.47205,701.38205,701.38
 减:营业外支出(元) 1,507,941.26696,847.19696,708.48318,232.3362,864.6755,561.93
五、利润总额(元) 105,344,021.2479,761,140.2474,876,620.39104,887,610.1877,029,866.6150,900,827.85
 减:所得税费用(元) 11,633,912.689,360,695.999,760,354.8411,601,408.489,954,324.466,607,011.08
六、净利润(元) 93,710,108.5670,400,444.2565,116,265.5593,286,201.7067,075,542.1544,293,816.77
(一)按经营持续性分类
  持续经营净利润(元) 93,710,108.5670,400,444.2565,116,265.5593,286,201.7067,075,542.1544,293,816.77
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 93,710,108.5670,400,444.2565,116,265.5593,286,201.7067,075,542.1544,293,816.77
 扣除非经常性损益后的净利润(元) 92,529,345.9468,960,771.3963,801,560.3886,487,337.3664,982,242.1537,588,439.74
七、每股收益
 一、基本每股收益(元) 0.950.710.660.950.680.45
 二、稀释每股收益(元) 0.950.710.660.950.680.45
九、综合收益总额(元) 93,710,108.5670,400,444.2565,116,265.5593,286,201.7067,075,542.1544,293,816.77
 归属于母公司所有者的综合收益总额(元) 93,710,108.5670,400,444.2565,116,265.5593,286,201.7067,075,542.1544,293,816.77
公告日期 2024-03-222023-10-302023-08-292023-04-102022-12-022022-08-01
审计意见(境内) 标准无保留意见标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院